Education & Training
1992, Vanderbilt University
Medical / Professional School(s)
1997, Keck Medical Center of USC (Keck Hospital of USC)
1998, General Surgery - Massachusetts General Hospital
2004, General Surgery - Massachusetts General Hospital
2005, Laparoscopic Surgery - Carolinas Medical Center
2002, Minimally Invasive Surgery - Cleveland Clinic
Gastrointestinal Surgery, Gastrointestional Cancer, Hernia Surgery, Laparoscopic and Minimally Invasive Surgery, Upper Gastrointestinal Cancer
Is It Time to Reconsider Postoperative Epidural Analgesia in Patients Undergoing Elective Ventral Hernia Repair?: An AHSQC Analysis.
Prabhu AS, Krpata DM, Perez A, Phillips S, Huang LC, Haskins IN, Rosenblatt S, Poulose BK, Rosen MJ
Concurrent ventral hernia repair in patients undergoing laparoscopic bariatric surgery: a case-matched study using the National Surgical Quality Improvement Program Database.
Khorgami Z, Haskins IN, Aminian A, Andalib A, Rosen MJ, Brethauer SA, Schauer PR
Onlay with Adhesive Use Compared with Sublay Mesh Placement in Ventral Hernia Repair: Was Chevrel Right? An Americas Hernia Society Quality Collaborative Analysis.
Haskins IN, Voeller GR, Stoikes NF, Webb DL, Chandler RG, Phillips S, Poulose BK, Rosen MJ
Recipient vessels for microsurgical flaps to the abdomen: A systematic review.
Gurunluoglu R, Rosen MJ
Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-only Crohn's Disease in Treatment-naïve Pediatric Patients.
Rosen MJ, Karns R, Vallance JE, Bezold R, Waddell A, Collins MH, Haberman Y, Minar P, Baldassano RN, Hyams JS, Baker SS, Kellermayer R, Noe JD, Griffiths AM, Rosh JR, Crandall WV, Heyman MB, Mack DR, Kappelman MD, Markowitz J, Moulton DE, Leleiko NS, Walters TD, Kugathasan S, Wilson KT, Hogan SP, Denson LA
Preoperative Chlorhexidine Gluconate Use Can Increase Risk for Surgical Site Infections after Ventral Hernia Repair.
Prabhu AS, Krpata DM, Phillips S, Huang LC, Haskins IN, Rosenblatt S, Poulose BK, Rosen MJ
Multicenter, Prospective, Longitudinal Study of the Recurrence, Surgical Site Infection, and Quality of Life After Contaminated Ventral Hernia Repair Using Biosynthetic Absorbable Mesh: The COBRA Study.
Rosen MJ, Bauer JJ, Harmaty M, Carbonell AM, Cobb WS, Matthews B, Goldblatt MI, Selzer DJ, Poulose BK, Hansson BM, Rosman C, Chao JJ, Jacobsen GR
Response to Letter to The Editor Regarding the COBRA Trial: What Will it Take to Perform High-quality Hernia Research?
Antibiotic-releasing microspheres prevent mesh infection in vivo.
Grafmiller KT, Zuckerman ST, Petro C, Liu L, von Recum HA, Rosen MJ, Korley JN
Development of a Disease-based Hernia Program and the Impact on Cost for a Hospital System.
Krpata DM, Haskins IN, Rosenblatt S, Grundfest S, Prabhu A, Rosen MJ
Patient Satisfaction Reviews
About Our Survey
At University Hospitals, we believe in providing patients with all the information they need to make educated decisions
about their health care and to choose the right doctor to meet their needs. That is why we partner with the independent
patient satisfaction company Press Ganey to survey patients about their experiences at UH facilities and with UH physicians.
We hold ourselves to the highest standards of care and are dedicated to creating a positive patient experience for
every individual who sees a UH doctor.
There are no comments for this practitioner.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2015, Michael Rosen, MD disclosed the following Outside Relationships with Industry:
Davol - Consulting
LifeCell - Consulting